Highlights

[PHARMA] YoY Quarter Result on 2015-12-31 [#4]

Stock [PHARMA]: PHARMANIAGA BHD
Announcement Date 15-Feb-2016
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2015
Quarter 31-Dec-2015  [#4]
Profit Trend QoQ -     -19.57%    YoY -     -56.23%
Quarter Report


View:


Show?  YoY % Horiz. %

Quarter Result
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Revenue 596,644 613,196 582,816 680,150 627,103 567,860 482,404 3.60%
  YoY % -2.70% 5.21% -14.31% 8.46% 10.43% 17.71% -
  Horiz. % 123.68% 127.11% 120.81% 140.99% 130.00% 117.71% 100.00%
PBT 11,940 19,866 4,069 23,717 37,854 33,007 4,248 18.79%
  YoY % -39.90% 388.23% -82.84% -37.35% 14.68% 677.00% -
  Horiz. % 281.07% 467.66% 95.79% 558.31% 891.10% 777.00% 100.00%
Tax -7,370 2,222 -4,969 -7,676 -1,233 -11,740 -11,716 -7.43%
  YoY % -431.68% 144.72% 35.27% -522.55% 89.50% -0.20% -
  Horiz. % 62.91% -18.97% 42.41% 65.52% 10.52% 100.20% 100.00%
NP 4,570 22,088 -900 16,041 36,621 21,267 -7,468 -
  YoY % -79.31% 2,554.22% -105.61% -56.20% 72.20% 384.78% -
  Horiz. % -61.19% -295.77% 12.05% -214.80% -490.37% -284.78% 100.00%
NP to SH 4,437 21,700 -836 16,062 36,697 20,813 -7,934 -
  YoY % -79.55% 2,695.69% -105.20% -56.23% 76.32% 362.33% -
  Horiz. % -55.92% -273.51% 10.54% -202.45% -462.53% -262.33% 100.00%
Tax Rate 61.73 % -11.18 % 122.12 % 32.36 % 3.26 % 35.57 % 275.80 % -22.07%
  YoY % 652.15% -109.15% 277.38% 892.64% -90.83% -87.10% -
  Horiz. % 22.38% -4.05% 44.28% 11.73% 1.18% 12.90% 100.00%
Total Cost 592,074 591,108 583,716 664,109 590,482 546,593 489,872 3.21%
  YoY % 0.16% 1.27% -12.11% 12.47% 8.03% 11.58% -
  Horiz. % 120.86% 120.67% 119.16% 135.57% 120.54% 111.58% 100.00%
Net Worth 509,862 526,888 531,169 529,786 525,351 486,672 472,037 1.29%
  YoY % -3.23% -0.81% 0.26% 0.84% 7.95% 3.10% -
  Horiz. % 108.01% 111.62% 112.53% 112.23% 111.29% 103.10% 100.00%
Dividend
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Div 5,202 15,573 7,773 18,134 31,055 16,049 11,771 -12.72%
  YoY % -66.59% 100.34% -57.14% -41.61% 93.49% 36.34% -
  Horiz. % 44.20% 132.29% 66.03% 154.05% 263.82% 136.34% 100.00%
Div Payout % 117.26 % 71.77 % - % 112.90 % 84.63 % 77.11 % - % -
  YoY % 63.38% 0.00% 0.00% 33.40% 9.75% 0.00% -
  Horiz. % 152.07% 93.07% 0.00% 146.41% 109.75% 100.00% -
Equity
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Net Worth 509,862 526,888 531,169 529,786 525,351 486,672 472,037 1.29%
  YoY % -3.23% -0.81% 0.26% 0.84% 7.95% 3.10% -
  Horiz. % 108.01% 111.62% 112.53% 112.23% 111.29% 103.10% 100.00%
NOSH 260,134 259,551 259,107 259,064 258,794 258,868 117,715 14.12%
  YoY % 0.22% 0.17% 0.02% 0.10% -0.03% 119.91% -
  Horiz. % 220.99% 220.49% 220.11% 220.08% 219.85% 219.91% 100.00%
Ratio Analysis
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
NP Margin 0.77 % 3.60 % -0.15 % 2.36 % 5.84 % 3.75 % -1.55 % -
  YoY % -78.61% 2,500.00% -106.36% -59.59% 55.73% 341.94% -
  Horiz. % -49.68% -232.26% 9.68% -152.26% -376.77% -241.94% 100.00%
ROE 0.87 % 4.12 % -0.16 % 3.03 % 6.99 % 4.28 % -1.68 % -
  YoY % -78.88% 2,675.00% -105.28% -56.65% 63.32% 354.76% -
  Horiz. % -51.79% -245.24% 9.52% -180.36% -416.07% -254.76% 100.00%
Per Share
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
RPS 229.36 236.25 224.93 262.54 242.32 219.36 409.81 -9.22%
  YoY % -2.92% 5.03% -14.33% 8.34% 10.47% -46.47% -
  Horiz. % 55.97% 57.65% 54.89% 64.06% 59.13% 53.53% 100.00%
EPS 1.71 8.36 -0.32 6.20 14.18 8.04 -6.74 -
  YoY % -79.55% 2,712.50% -105.16% -56.28% 76.37% 219.29% -
  Horiz. % -25.37% -124.04% 4.75% -91.99% -210.39% -119.29% 100.00%
DPS 2.00 6.00 3.00 7.00 12.00 6.20 10.00 -23.52%
  YoY % -66.67% 100.00% -57.14% -41.67% 93.55% -38.00% -
  Horiz. % 20.00% 60.00% 30.00% 70.00% 120.00% 62.00% 100.00%
NAPS 1.9600 2.0300 2.0500 2.0450 2.0300 1.8800 4.0100 -11.24%
  YoY % -3.45% -0.98% 0.24% 0.74% 7.98% -53.12% -
  Horiz. % 48.88% 50.62% 51.12% 51.00% 50.62% 46.88% 100.00%
Adjusted Per Share Value based on latest NOSH - 261,230
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
RPS 228.40 234.73 223.10 260.36 240.06 217.38 184.67 3.60%
  YoY % -2.70% 5.21% -14.31% 8.46% 10.43% 17.71% -
  Horiz. % 123.68% 127.11% 120.81% 140.99% 129.99% 117.71% 100.00%
EPS 1.70 8.31 -0.32 6.15 14.05 7.97 -3.04 -
  YoY % -79.54% 2,696.88% -105.20% -56.23% 76.29% 362.17% -
  Horiz. % -55.92% -273.36% 10.53% -202.30% -462.17% -262.17% 100.00%
DPS 1.99 5.96 2.98 6.94 11.89 6.14 4.51 -12.74%
  YoY % -66.61% 100.00% -57.06% -41.63% 93.65% 36.14% -
  Horiz. % 44.12% 132.15% 66.08% 153.88% 263.64% 136.14% 100.00%
NAPS 1.9518 2.0169 2.0333 2.0280 2.0111 1.8630 1.8070 1.29%
  YoY % -3.23% -0.81% 0.26% 0.84% 7.95% 3.10% -
  Horiz. % 108.01% 111.62% 112.52% 112.23% 111.29% 103.10% 100.00%
Price Multiplier on Financial Quarter End Date
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Date 31/12/18 29/12/17 30/12/16 31/12/15 31/12/14 31/12/13 31/12/12 -
Price 2.7800 4.6000 5.3000 6.3600 4.5800 4.4500 8.1000 -
P/RPS 1.21 1.95 2.36 2.42 1.89 2.03 1.98 -7.88%
  YoY % -37.95% -17.37% -2.48% 28.04% -6.90% 2.53% -
  Horiz. % 61.11% 98.48% 119.19% 122.22% 95.45% 102.53% 100.00%
P/EPS 162.99 55.02 -1,642.66 102.58 32.30 55.35 -120.18 -
  YoY % 196.24% 103.35% -1,701.35% 217.59% -41.64% 146.06% -
  Horiz. % -135.62% -45.78% 1,366.83% -85.36% -26.88% -46.06% 100.00%
EY 0.61 1.82 -0.06 0.97 3.10 1.81 -0.83 -
  YoY % -66.48% 3,133.33% -106.19% -68.71% 71.27% 318.07% -
  Horiz. % -73.49% -219.28% 7.23% -116.87% -373.49% -218.07% 100.00%
DY 0.72 1.30 0.57 1.10 2.62 1.39 1.23 -8.53%
  YoY % -44.62% 128.07% -48.18% -58.02% 88.49% 13.01% -
  Horiz. % 58.54% 105.69% 46.34% 89.43% 213.01% 113.01% 100.00%
P/NAPS 1.42 2.27 2.59 3.11 2.26 2.37 2.02 -5.70%
  YoY % -37.44% -12.36% -16.72% 37.61% -4.64% 17.33% -
  Horiz. % 70.30% 112.38% 128.22% 153.96% 111.88% 117.33% 100.00%
Price Multiplier on Announcement Date
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Date 21/02/19 27/02/18 21/02/17 15/02/16 23/02/15 24/02/14 18/02/13 -
Price 2.7600 4.0400 5.1200 6.1900 5.2800 4.2900 7.8000 -
P/RPS 1.20 1.71 2.28 2.36 2.18 1.96 1.90 -7.37%
  YoY % -29.82% -25.00% -3.39% 8.26% 11.22% 3.16% -
  Horiz. % 63.16% 90.00% 120.00% 124.21% 114.74% 103.16% 100.00%
P/EPS 161.81 48.32 -1,586.88 99.84 37.24 53.36 -115.73 -
  YoY % 234.87% 103.04% -1,689.42% 168.10% -30.21% 146.11% -
  Horiz. % -139.82% -41.75% 1,371.19% -86.27% -32.18% -46.11% 100.00%
EY 0.62 2.07 -0.06 1.00 2.69 1.87 -0.86 -
  YoY % -70.05% 3,550.00% -106.00% -62.83% 43.85% 317.44% -
  Horiz. % -72.09% -240.70% 6.98% -116.28% -312.79% -217.44% 100.00%
DY 0.72 1.49 0.59 1.13 2.27 1.45 1.28 -9.14%
  YoY % -51.68% 152.54% -47.79% -50.22% 56.55% 13.28% -
  Horiz. % 56.25% 116.41% 46.09% 88.28% 177.34% 113.28% 100.00%
P/NAPS 1.41 1.99 2.50 3.03 2.60 2.28 1.95 -5.26%
  YoY % -29.15% -20.40% -17.49% 16.54% 14.04% 16.92% -
  Horiz. % 72.31% 102.05% 128.21% 155.38% 133.33% 116.92% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Stock Screener using Technical and Fundamental criteria
MQ Affiliate
Join the MQ Affiliate Program today to earn rewards
 
 

236  475  591  1149 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AT 0.095+0.005 
 VC 0.05-0.005 
 MAHSING 0.975-0.025 
 DATAPRP 0.20-0.02 
 KSTAR 0.445+0.075 
 LUSTER 0.165-0.005 
 SUPERMX-C1I 0.15-0.005 
 DGSB 0.22+0.005 
 SUPERMX 9.59-0.19 
 VIVOCOM 0.0450.00 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Supermax: my revised target price - Koon Yew Yin Koon Yew Yin's Blog
2. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
3. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
4. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
5. Najib Facebook Post comments on GLOVES. What's the message? gloveharicut
6. [Humbled Investor] Supermx - Superb results - Estimation on Next QR Results HumbledInvestor
7. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
8. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
PARTNERS & BROKERS